pillbase.ru

BESREMi

Active substance: ropeginterferon alfa-2b

INJECTION · ROPEGINTERFERON ALFA-2B 500 ug/mL

United StatesActive

Marketing holder: PharmaEssentia USA

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Besremi
    ropeginterferon alfa-2b
    EMEA/H/C/004128
    AOP Orphan Pharmaceuticals GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2ee9-7a75-a790-ad529013ff4a,01a1208c-2eea-77cc-9038-35d723b3b0d8;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
73536-500
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 73536-500 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 73536-500 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 73536-500 · Verified 2026-10-09 · open in source